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Introduction
The presence of IgG oligoclonal bands indicates an increased risk for developing multiple sclerosis in patients presenting with clinically isolated syndromes (CIS) (McDonald et al., 2001; Polman et al., 2005; Tintore et al., 2008 Tintore et al., , 2015 Zipoli et al., 2009) independently of other risk factors (Tintore et al., 2008 (Tintore et al., , 2015 Zipoli et al., 2009) . In fact, the 2001 McDonald criteria for the diagnosis of multiple sclerosis and their 2005 revision allowed an alternative dissemination in space (DIS) criterion comprised by the presence of two or more T 2 lesions on MRI plus positive oligoclonal bands (McDonald et al., 2001; Polman et al., 2005) . However, in the 2010 revisions, it was deemed inappropriate to further liberalize MRI requirements in CSF-positive patients as the contribution of oligoclonal bands status was not evaluated (Polman et al., 2011) . In this sense, a recent multicentre study showed that the diagnostic performance of 2010 DIS plus positive oligoclonal bands was similar to DIS alone (Huss et al., 2016) , whereas another study in children with optic neuritis demonstrated that the combination of MRI lesions and oligoclonal bands positivity was indicative of having multiple sclerosis (Heussinger et al., 2015) .
Therefore, the objective of this study was to explore the value of oligoclonal bands for multiple sclerosis diagnosis in the context of the 2010 McDonald criteria, especially in patients with a CIS typical for demyelination fulfilling only DIS at baseline. 
Materials and methods

Study cohort
Patients
CIS patients 550 years of age first seen within 3 months of disease onset were included (Tintore et al., 2015) . Demographic data, CIS topography, and disability according to the Expanded Disability Status Scale (EDSS) were recorded at baseline. Follow-up was performed every 3-6 months, assessing for relapses and disability according to the EDSS measured during stability periods.
IgG oligoclonal bands
Oligoclonal bands were determined in CSF and serum within the first 3 months by agarose isoelectric focusing combined with immunoblotting (Andersson et al., 1994; Freedman et al., 2005) .
MRI acquisition and analysis
The MRI protocol has been described elsewhere (Tintore et al., 2015; Arrambide et al., 2017) . Briefly, the baseline brain MRIs were performed within 3-5 months of disease onset and follow-up scans at 1 year and every 5 years thereafter. Baseline spinal cord MRIs were initially done if the presenting symptoms suggested a myelitis, and from 2007 they were obtained in all CIS cases. Scans were obtained at 3.0 T since 2010 and at 1.5 T previously. Brain sequences included transverse dual echo T 2 -weighted fast spin-echo, transverse and sagittal T 2 -FLAIR, and transverse T 1 -weighted spin-echo. From 2001, the transverse T 1 -weighted sequence was systematically repeated after gadolinium (Gd) injection (0.2 mmol/kg) in patients with lesions on T 2 -weighted images. Previous to that year, Gd was seldom administered. Spinal cord sequences included sagittal dual echo proton density/T 2 -weighted fast spin-echo, sagittal short-tau inversion-recovery (STIR) and, in patients with brain Gd T 1 -weighted sequences or spinal cord lesions, a Gd-enhanced sagittal T 1 -weighted. Axial T 2 -weighted sequences were performed, covering segments showing abnormalities on the sagittal images or with suspected involvement based on clinical findings.
All sequences were acquired with a contiguous 3-mm section thickness. MRI scans were assessed by one of two neuroradiologists blinded to clinical follow-up. In doubtful cases, the final analysis was based on their consensus opinion. MRIs were considered abnormal if one or more lesions were observed. The number and location of lesions on T 2 -weighted images, number of Gd-enhancing lesions, and number of active T 2 lesions on brain MRI were scored. Lesion number (0, 1, 2-3, 43) and presence of Gd enhancement on spinal cord MRI were scored.
Experimental design
From January 1995 to January 2016, we included 1214 patients in the CIS cohort. Of these, we excluded 71 (5.8%) during follow-up for having presented a previous demyelinating attack (n = 13), exceeding the age limit (n = 4), exceeding the entry window (n = 26), or reaching an alternative diagnosis (n = 28). Of the remaining 1143 patients, we selected the study groups as described below (Fig. 1) .
Risk assessment group
From this cohort, we selected patients who had both oligoclonal bands determination and sufficient information on the baseline brain MRI to assess DIS and dissemination in time (DIT) according to a modified version of the 2010 McDonald criteria (Polman et al., 2011) , taking into account the symptomatic lesions (Brownlee et al., 2016; Tintore et al., 2016) (n = 566). Of these patients, we excluded 168 (29.7%) already fulfilling DIS plus DIT and divided the remaining 398 into cases fulfilling 'DIS' (n = 164), 'DIT' (n = 16), and 'no DIS no DIT' (n = 218). Of the 577 non-selected patients out of 1143, 347 (60.1%) had oligoclonal bands determination but none of them had Gd data collected, mostly due to changes in the MRI protocol over time.
Diagnostic properties group
From the risk assessment cohort, we further selected cases with a minimum follow-up of 3 years or fulfilling the 2010
McDonald multiple sclerosis criteria within 3 years of the CIS (Swanton et al., 2007) . Of the resultant 314 cases, 'DIS' was fulfilled in 137, 'DIT' in 12, and 'no DIS no DIT' in 165.
Statistical analysis
Descriptive statistics were performed on demographic and clinical variables in both studied groups.
Risk assessment group
We performed uni-and multivariable Cox proportional hazards regression analyses, all with 95% confidence intervals (CI), with the modified 2010 McDonald criteria (fulfilled either clinically or radiologically) as the outcome after dividing the 'no DIS no DIT' cases into four subgroups: 0 lesions and negative oligoclonal bands (n = 91), which was used as the reference category; 0 lesions and positive oligoclonal bands (n = 16); 51 lesions and negative oligoclonal bands (n = 60); and 51 lesions and positive oligoclonal bands (n = 51). The 'DIS' subgroup was also divided according to oligoclonal bands status (negative, n = 42; and positive, n = 122). Due to the small number of cases fulfilling 'DIT' we did not divide this subgroup any further.
Covariates included age, gender, CIS topography, and disease-modifying treatment as a binary, time-dependent variable. 
Diagnostic properties group
We assessed the diagnostic properties of all DIS cases, regardless of the oligoclonal bands status (n = 137), and compared them to patients fulfilling DIS and with positive oligoclonal bands (n = 101) by use of 2010 McDonald at 3 years as the outcome. The remaining patients classified as fulfilling 'DIT' or 'no DIS no DIT' were taken into account when calculating the diagnostic properties. Table 1 shows the general characteristics of both the risk assessment and the diagnostic performance groups. Relative to the risk assessment group, the performance group had similar characteristics, except for a longer follow-up, more treated patients, and a higher proportion of patients developing multiple sclerosis.
Results
General characteristics
The data according to the different DIS or DIT subgroups are detailed in Table 2 . In both the risk assessment and performance groups, the proportion of patients with positive oligoclonal bands or starting a disease-modifying treatment was higher in 'DIS' than in 'DIT' and 'no DIS no DIT'. Additionally, more 'DIS' and 'DIT' patients reached the diagnosis of McDonald multiple sclerosis than 'no DIS no DIT' cases, with 'DIS' patients doing so earlier than 'DIT' cases, although without statistical significance [median (percentiles 25-75) 12.3 (7.4-20.5) versus 35.7 (16.8-47.6 ) months, respectively, P = 0.123]. Figure 2 shows the proportion of patients reaching the outcome according to the MRI-oligoclonal bands subgroups, which was 460.0% for both 'DIS' subgroups and for 'no DIS no DIT' with 51 lesions and positive oligoclonal bands. Figure 3 shows the corresponding median time to McDonald multiple sclerosis, which was shorter for both 'DIS' subgroups (P = 0.284 for all). Of note, the number of patients initiating DMT at any time was 0/91 (0%) in 'no DIS no DIT' with 0 lesions and negative oligoclonal bands, 1/16 (6.3%) in 'no DIS no DIT' with 0 lesions and positive oligoclonal bands, 10/60 (16.7%) in 'no DIS no DIT' with 51 lesions and negative oligoclonal bands, 24/51 (47.1%) in 'no DIS no DIT' with 51 lesions and positive oligoclonal bands, 22/42 (52.4%) in 'DIS and negative oligoclonal bands', 81/122 (66.4%) in 'DIS and positive oligoclonal bands', and 5/16 (31.3%) in 'DIT' (P 5 0.0001). Risk assessment group Figure 4 shows the uni-and multivariable results for the different studied subgroups. We observed a stepwise increase in the risk of developing multiple sclerosis over time that was not only dependent on DIS fulfilment or on the presence of T 2 lesions, but also on oligoclonal bands status. For instance, the risk was already high for patients with 'DIS and negative oligoclonal bands', but increased further in 'DIS with positive oligoclonal bands'. If considering all 'DIS' patients regardless of oligoclonal bands status, the adjusted hazard ratio was 9.5 (95% CI 5.0-18.1).
Diagnostic properties group Table 3 shows the diagnostic properties at 3 years for all 'DIS' and for 'DIS with positive oligoclonal bands'. The specificity for McDonald multiple sclerosis was 80.6 for all 'DIS' cases, and increased to 88.1 when selecting only the patients with positive oligoclonal bands.
Discussion
The 2010 McDonald criteria are highly specific for multiple sclerosis (Swanton et al., 2007; Rovira et al., 2009; Montalban et al., 2010) . Nevertheless, it is not uncommon to identify patients presenting a typical CIS and demyelinating lesions who do not fulfil these criteria at baseline (Caucheteux et al., 2015; Huss et al., 2016) . This, in part, could be due to the timing of the baseline MRI, which could modify the possibilities of demonstrating DIT (Rovira et al., 2009) . Therefore, identifying an alternative criterion to diagnose multiple sclerosis at baseline in these cases, without compromising specificity, becomes relevant. Additionally, the demonstration of CSF oligoclonal bands, indicating chronic inflammatory activity within the CNS, increases the diagnostic confidence. In the present study, the median time to reach the diagnosis of multiple sclerosis was approximately 1 year after the CIS for both 'DIS' subgroups, and the proportion of patients doing so was 7.8-12.0% higher if oligoclonal bands were present, depending on the studied group (risk assessment and performance groups, respectively). However, given the difference in the number of patients in each category, when looking at the absolute numbers, McDonald multiple sclerosis was diagnosed in 59 more cases in the 'DIS with positive oligoclonal bands' subgroup, of which 38 did so during the first 12 months of disease evolution, compared to seven in the 'DIS with negative oligoclonal bands' subgroup, suggesting that in patients already fulfilling DIS, the note, during the first 6 months, 12 patients with DIS and positive oligoclonal bands (OB) fulfilled McDonald multiple sclerosis compared to five patients with DIS with negative oligoclonal bands; during months 6-12, the outcome was fulfilled by 26 and 2, respectively; and during the 12-13 month period by 16 and 6, respectively. Notice that at the end of the 6-12 month and throughout the 12-13 month periods the number of patients fulfilling the outcome increases greatly also due to DIT fulfilment on the 12-month follow-up MRI. MS = multiple sclerosis. patients with negative oligoclonal bands (Huss et al., 2016) . The proportion of patients with positive oligoclonal bands having multiple sclerosis was even greater in a multicentre study of children with optic neuritis, especially when combined with an abnormal brain MRI (i.e. one or more demyelinating lesions) (Heussinger et al., 2015) . As for the risk of developing multiple sclerosis over time, Huss and colleagues demonstrated a 2-fold increase in patients with positive oligoclonal bands in their univariable analysis, which is in-line with previous findings (Tintore et al., 2008 (Tintore et al., , 2015 Huss et al., 2016) . In their multivariable analyses, Heussinger and colleagues (Heussinger et al., 2015) demonstrated that in patients with both an abnormal MRI and presence of oligoclonal bands at baseline, the risk for developing multiple sclerosis was more than 20 times higher than in patients with negative findings on MRI and CSF. Although the results from these two studies do demonstrate the value of oligoclonal bands in the general context of the 2010 McDonald criteria, their results were not split according to the subgroups hereby presented, which could aid in discriminating those in which the presence of oligoclonal bands could be more valuable, like in patients already fulfilling DIS. Besides, our results may not be easily comparable to the findings by Heussinger et al. (2015) , given patients with alternative diagnoses were included in their non-multiple sclerosis subgroup whereas we excluded such cases from our database. Taken together, all these results suggest that patients with CIS fulfilling DIS at baseline will probably develop multiple sclerosis early in the disease course and the risk of doing so increases if oligoclonal bands are positive, even more so than DIT cases in our study. Concerning the diagnostic properties, the specificity for multiple sclerosis diagnosis at 3 years was higher for DIS cases with positive oligoclonal bands than for all DIS cases, regardless of oligoclonal bands status. This is in contrast to the results reported by Huss and colleagues (Huss et al., 2016) , which showed similar results for both. This difference could be due to the time-point established to assess the outcome, which was 1 year longer in our study. A high specificity is an important aspect of performance in multiple sclerosis diagnosis considering the potential initiation of DMT. Such high specificity was not compromised when the current, simpler criteria for DIS were first assessed, as long as DIT was also present. However, the lower specificity of DIS alone (59.0%) suggested that 52 lesions in 52 typical locations were insufficient to diagnose multiple sclerosis (Swanton et al., 2007) . In this sense, our study shows that adding positive oligoclonal bands to DIS increases the specificity of multiple sclerosis diagnosis, suggesting 'DIS plus positive oligoclonal bands' could be used as an alternative to diagnose multiple sclerosis if DIT is not fulfilled at baseline.
Of note, the 'no DIS no DIT' subgroup with 51 lesions and positive oligoclonal bands had a higher risk for fulfilling McDonald multiple sclerosis than 'no DIS no DIT' with 51 lesions and negative oligoclonal bands, and had a very similar proportion of patients reaching the outcome as that of 'DIS with negative oligoclonal bands'. Previous studies have shown that the proportion of patients developing a second demyelinating attack was higher in patients not fulfilling the Barkhof-Tintore criteria but presenting with positive oligoclonal bands compared to those with negative oligoclonal bands (Tintore et al., 2008; Zipoli et al., 2009) , and similar results were reported for patients with 0 lesions and positive oligoclonal bands when assessing the 2010 criteria (Huss et al., 2016) . Additionally, it has been demonstrated that one single lesion, whether asymptomatic or not, increases the risk of developing multiple sclerosis in typical CIS (Brownlee et al., 2016; Tintore et al., 2016) , and that patients with a lower lesion load require a longer time to develop multiple sclerosis (Fisniku et al., 2008; Brownlee et al., 2016; Tintore et al., 2016) . Considering the possible added value of positive oligoclonal bands in such instances, a previous study in CIS patients not fulfilling the 2010 DIS criteria showed that combinations of other predictive factors, including oligoclonal bands, increased the risk of multiple sclerosis 2.7-3.6 times (Ruet et al., 2014) . Nevertheless, relying on very few lesions without DIT to diagnose multiple sclerosis could be too liberal and lead to diagnostic errors in the daily clinical practice. In such cases, considering the presence of oligoclonal bands could be relevant due to the increased risk for developing multiple sclerosis independently of MRI findings (Tintore et al., 2008 (Tintore et al., , 2015 Dobson et al., 2013) . Therefore, future studies should focus on these subgroups to further evaluate their specificity and/or risk of misdiagnosis, always taking into account that these criteria should be applied to CIS suggestive of multiple sclerosis.
One limitation of this study is the sample size of the DIT subgroup, which could influence both its results and the possibility to assess the role of oligoclonal bands in these cases. Another limitation is the lower number of spinal cord MRIs performed, which could lead to the misclassification of some cases among the different subgroups. However, given the moderate added value of spinal cord lesions to multiple sclerosis diagnosis at baseline in our cohort (Arrambide et al., 2017) , the number of potential misclassifications is probably low. One more limitation is the inclusion of patients starting treatment before reaching the studied outcome. Whereas this is corrected by adding DMT as a time-dependent variable in the multivariable analysis for risk assessment, DMT initiation could have a potential confounding effect in the analysis concerning the diagnostic properties. Nevertheless, we considered that excluding the patients treated before reaching the outcome would result in a selection bias given their high proportion in the DIS subgroups, and therefore decided to include them all in the present study. A likely limitation, in general, to the usefulness of oligoclonal bands in multiple sclerosis diagnosis, is the determination technique itself, which is rater-dependent (Freedman et al., 2005) . However, a possible future alternative is the measurement of CSF kappafree light chains, which is a rapid, quantitative, and easy to standardize tool, almost equal to oligoclonal bands with regard to diagnostic sensitivity and specificity in patients with early multiple sclerosis (Senel et al., 2014; Presslauer et al., 2016; Voortman et al., 2017) .
Importantly, using oligoclonal bands to diagnose multiple sclerosis is not novel: the Poser criteria already proposed that, in CIS patients, laboratory-supported definite multiple sclerosis was fulfilled in those with either clinical evidence of two lesions and positive CSF findings, or with clinical evidence of one lesion, paraclinical evidence of another lesion, and positive CSF findings (Poser et al., 1983) . Besides, the 2001 McDonald criteria for the diagnosis of multiple sclerosis and their 2005 revision allowed an alternative DIS criterion comprised by the presence of two or more T 2 lesions on MRI plus positive oligoclonal bands (McDonald et al., 2001; Polman et al., 2005) . More recent studies and ours present further evidence of the role of oligoclonal bands in multiple sclerosis diagnosis, which is, to date, the second clearest diagnostic marker after MRI. In conclusion, according to these results, we propose MRI DIS at any time plus positive oligoclonal bands as an additional criterion for multiple sclerosis diagnosis in patients presenting with a CIS typical for demyelination.
